New generation skin sensitisation testing technologies explained
REGISTER FOR OUR FREE WEBINAR
Tuesday 15th September
3.00 – 3.30pm BST
In vitro skin sensitisation testing has come a long way in recent years, with the adoption of genomic technology proving to be a particularly exciting development with great potential.
GARD® tests combine genomic data from a relevant human cell type with machine learning to create a prediction model for identification of chemical sensitisers. This holistic, information-rich approach provides prediction accuracy exceeding 90%.
XCellR8 have partnered with SenzaGen to bring you this half hour webinar to explain more about how these methods work, from determining potency to animal-product-free solutions.
You will learn:
- How GARD assays can be used for the safety assessment of chemicals, formulations and finished products
- How the new animal-product-free version of GARD®skin can help support vegan tested claims
- How GARD is meeting the challenges of skin sensitisation potency and dose-response
Who should attend?
This webinar is designed for anyone involved in cosmetic product development, including formulators, regulatory managers, safety assessors and toxicologists. You don’t need a technical background on genomics, machine learning or programming.